High-affinity HPV L1 Antibodies

HPV L1 Antibodies from Creative Diagnostics provide dependable tools for human papillomavirus detection and identification because of their high-affinity and high-specificity capabilities. The antibodies achieve superior sensitivity and precise detection and reliable results through advanced immunoassay development and strict quality control procedures. The antibody products undergo complete validation testing to verify their performance consistency and shelf life extension and their ability to identify HPV types accurately. The HPV L1 Antibodies support multiple applications which include HPV diagnostics and vaccine development and immunology research and disease surveillance and assay development to help detect HPV early and identify it accurately and support worldwide HPV prevention and control initiatives.

Talk to our experts Available Products

Why Choose Creative Diagnostics' HPV L1 Antibodies?

HPV L1 antibodies from Creative Diagnostics deliver superior performance results when used in immunoassay applications. The antibodies undergo strict quality control tests to achieve high sensitivity and specific binding and reliable results and long-term stability for diagnostic and research applications. The antibodies find multiple uses in HPV research for detecting infections and vaccine development and immunological studies and disease monitoring and assay improvement. Our product advantages:

• High specificity: Accurately recognizes the HPV L1 major capsid protein, minimizing cross-reactivity.
• High affinity: Stably binds to the target antigen, ensuring detection sensitivity.
• Superior sensitivity: Suitable for detecting low-level HPV infection or early-stage infection.
• Robust reproducibility: High batch-to-batch consistency ensures reliable experimental results.
• Validated performance: Rigorously validated and compatible with various immunology platforms (ELISA, Western blot, IFA, etc.).
• Extended stability: Provides long-term shelf life and excellent resistance to degradation.
• Versatile applications: Suitable for diagnostics, vaccine evaluation, epidemiological studies, and immunological mechanism exploration.

Get a Quote

Case Study

HPV L1 Antibodies serve as essential tools for measuring HPV vaccine-induced immune responses.

Background:

Human papillomavirus (HPV) causes most cervical cancer cases and L1-based virus-like particle (VLP) vaccines serve as the primary defense against infection. The correct measurement of vaccine-induced immune responses remains vital for both vaccine research and clinical trial operations.

Objective:

The study aimed to assess the antibody response of people who received the HPV L1 VLP-based vaccine through the use of high-quality HPV L1 Antibodies.

Method:

The researchers used ELISA and Western blot and immunofluorescence assays with HPV L1 Antibodies to detect L1-specific IgG and neutralizing antibodies in serum samples obtained from vaccinated participants. The researchers implemented multiple control measures to verify both test precision and result consistency.

Results:

• ELISA a strong relationship with the results obtained from the neutralization assay.
• The assay showed excellent results between different tests detected L1-specific antibodies at high levels throughout all vaccinated participants.
• The ELISA titers showed batches while producing very low background signals.

HPV L1 Antibodies functioned as a dependable method to track vaccine-induced immune system responses because of their high sensitivity. The antibodies demonstrated both high specificity and reproducibility which enabled precise seroconversion assessment for vaccine development and immunological research.